In conclusion, above findings clarified the effect of CD8A epigenetic modifications on CTL levels and T cell dysfunctional states, which may contribute to the prognosis of patients with different tumor types, providing compelling evidence for disparities in opposite prognosis in various cancer types. This evidence concerns the gene CD8A and neoplasm.